PrimeRFP SCOUT · Federal Contract Recompete Brief

HT001122D0053Omnibus IV military medical research and — Vysnova Partners, Inc

Vysnova Partners, Inc holds $50.5M across 65 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 2 related awards in the incumbent pipeline. Set-aside status: Unrestricted.

Defense Health Agency
Awarding office
Vysnova Partners, Inc
Recipient
—
Estimated value
AN14
PSC
Unrestricted
Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract numberHT001122D0053
Also listed asHT0011-22-D-0053
AgencyDefense Health Agency
Awarding officeDefense Health Agency
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentVysnova Partners, Inc
UEIWG9BBL96G436
PSCAN14
Related solicitationHT001121R0004

OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT SERVICES is a federal Unrestricted award for Defense Health Agency held by Vysnova Partners, Inc. Estimated value —. Related solicitation HT001121R0004.

OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT SERVICES

Bonuses end Sept 30

Want the durability read on HT001122D0053? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Vysnova Partners, Inc — $50.5M obligated across 65 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($50.5M) · all agencies
Department of Defense (DOD)$46.0M · 91%Department of Health and Human Services (HHS)$4.2M · 8%Department of Transportation (DOT)$326K · 1%
Open full company profile →

Related awards

Same incumbent
N0018926FA001
RESEARCH AND ADMINISTRATION SUPPORT SERVICES IN SUPPORT OF NAVAL MEDICAL RESEARCH UNIT SOU…
$4.6M
Mar 30, 2027
HT942524F0319
CLINICAL RESEARCH SUPPORT SERVICES
$1.5M
Sep 27, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract HT001122D0053?

HT001122D0053 (Omnibus IV military medical research and) is a Defense Health Agency award with an estimated value of —, currently held by Vysnova Partners, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is HT0011-22-D-0053?

HT0011-22-D-0053 is the dashed form of PIID HT001122D0053 (Omnibus IV military medical research and), held by Vysnova Partners, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded HT001122D0053?

Defense Health Agency awarded HT001122D0053 to Vysnova Partners, Inc.

Who is the incumbent on HT001122D0053?

Vysnova Partners, Inc is the incumbent with $50.5M across 65 related awards in SCOUT’s public footprint.

When does Vysnova Partners, Inc’s HT001122D0053 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on HT001122D0053? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/HT001122D0053